Trial Profile
A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2011
Price :
$35
*
At a glance
- Drugs Octocog alfa (Primary)
- Indications Haemophilia A; Joint disorders
- Focus Therapeutic Use
- Acronyms ESPRIT
- 28 Jul 2011 Qulaity of life results presented at the 23rd Congress of the International Society on Thrombosis and Haemostasis.
- 29 Mar 2011 New trial record